Intermedics PMA for cementless Natural Knee is approvable -- FDA panel.
This article was originally published in The Gray Sheet
Executive Summary
INTERMEDICS ORTHOPEDICS PMA FOR CEMENTLESS NATURAL KNEE needs additional benchtop fatigue testing data before it can be approved, FDA's Orthopedic and Rehabilitation Devices Panel concluded at a June 12 meeting in Gaithersburg, Maryland. The request for enhanced fatigue testing data, which the panel said should include additional comparisons to other prostheses, was one of several conditions placed on the advisory group's unanimous approvable recommendation for the premarket approval application. The panel's recommendation covered cementless implantation of the Natural Knee in patients suffering from either inflammatory joint disease or non-inflammatory degenerative joint disease.
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.